0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Drug Delivery Devices Market Report 2025

  • PDF Icon

    Report

  • 250 Pages
  • March 2025
  • Region: Global
  • The Business Research Company
  • ID: 5939645
The drug delivery devices market size has grown strongly in recent years. It will grow from $91.03 billion in 2024 to $96.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rapid growth in elderly population, growth in the number of healthcare facilities, economic growth in the emerging markets and increased healthcare expenditure.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $124.82 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increase in prevalence of chronic diseases, increasing demand from injectables, increasing demand for drug delivery devices and sudden emergence of severe infections. Major trends in the forecast period include investing in microneedle drug technology for drug delivery, research and development of self-injectable drug delivery devices, focusing on mergers and acquisitions and investing in wearable drug delivery devices.

The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, and other conditions is expected to propel the drug delivery devices market. For example, in January 2023, according to the National Library of Medicine, the number of individuals in the United States aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Various routes of drug administration exist, and the choice depends on three factors, the desired effect, the type of disease, and the product type. The pharmaceutical industry is currently emphasizing the development of new drug delivery systems, driven by increasing R&D efforts worldwide due to the rising prevalence of chronic diseases. Many pharmaceutical companies are concentrating on multiple drug delivery technologies to enhance advantages and improve outcomes for their products. Therefore, the growing prevalence of chronic diseases is leading to increased consumption of therapeutic drugs and therapies, acting as a driver for the drug delivery devices market's growth.

The growth of the drug delivery devices market is expected to be driven by increasing healthcare spending in the future. Healthcare spending encompasses the total financial resources allocated to health services and goods, which includes expenses related to hospitals, physicians, nursing care, prescription medications, and public health initiatives. This rise in healthcare spending is attributed to factors such as an aging population, a growing prevalence of chronic diseases, advancements in medical technology, and escalating costs associated with healthcare services and prescription drugs. Greater healthcare expenditure facilitates the development of drug delivery devices by providing additional funding for research, innovation, and the implementation of advanced technologies that enhance treatment efficacy and improve patient outcomes. For example, in May 2024, the Office for National Statistics, a UK government department, reported that healthcare expenditure in the UK reached approximately $379 billion (£292 billion) in 2023. This represented a nominal increase of 5.6% compared to 2022, a significant rise from the 0.9% growth noted in the previous year. Consequently, the increasing healthcare spending is driving the growth of the drug delivery devices market.

Major companies in the drug delivery device market are concentrating on developing innovative solutions, such as autoinjectors with fully integrated connectivity, to secure a competitive advantage. Autoinjectors are medical devices designed for the self-administration of a pre-measured dose of medication. For example, in May 2022, Jabil Healthcare, a U.S.-based provider of healthcare manufacturing solutions, introduced the Qfinity autoinjector platform, which is a reusable drug delivery device. The Qfinity platform is notable for being a simple, reusable, and modular solution for subcutaneous self-administration of drugs, offering a cost-effective alternative to competitors while supporting sustainable drug delivery practices within the pharmaceutical industry. Its versatile design accommodates various drug volumes and viscosities and features a patient-centric form factor, achieving up to 65% lower cost per injection compared to leading disposable autoinjectors. The robust Qfinity device is capable of supporting over 100 injections and utilizes 1 mL or 2.25 mL pre-filled disposable cassettes. Furthermore, its reduced component and material consumption leads to an estimated 65% reduction in cost per injection, a 60% smaller carbon footprint, a 50% reduction in manufacturing footprint, and a 70% decrease in capital expenditure (CAPEX).

Microneedle (MN) technology is recognized for its efficiency and versatility in the medical device landscape, boasting attributes such as painless penetration, cost-effectiveness, high therapeutic efficacy, and relative safety. Key players in the global microneedle drug delivery system market include 3M, Vetter Pharma International GmbH, Nano Biosciences LLC, Nano Pass, and others. Microneedles are crafted using biodegradable polymers that encapsulate drugs or vaccines. Upon dissolution in the skin, the microneedles release the drug. This innovative delivery method facilitates the passage of a diverse range of molecules through the skin barrier, allowing transdermal delivery for various clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition aligns with Sandoz's strategic goal of expanding its current respiratory medication portfolio and enhancing patient access to advanced treatments. Coalesce Product Development Limited, based in the UK, specializes in the manufacturing of respiratory medical and medication delivery devices.

Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc.

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Drug delivery devices are designed to administer specific drugs to targeted areas of the body for disease treatment. These devices find application in various patient care environments, including hospitals, diagnostic centers, clinics, and home care settings.

The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.

The drug delivery devices market research report is one of a series of new reports that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Drug Delivery Devices Market Characteristics3. Drug Delivery Devices Market Trends and Strategies4. Drug Delivery Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market
5. Global Drug Delivery Devices Growth Analysis and Strategic Analysis Framework
5.1. Global Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis of End Use Industries
5.3. Global Drug Delivery Devices Market Growth Rate Analysis
5.4. Global Drug Delivery Devices Historic Market Size and Growth, 2019-2024, Value ($ Billion)
5.5. Global Drug Delivery Devices Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Billion)
5.6. Global Drug Delivery Devices Total Addressable Market (TAM)
6. Drug Delivery Devices Market Segmentation
6.1. Global Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
6.2. Global Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Other Patient Care Settings
6.3. Global Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Other Applications
6.4. Global Drug Delivery Devices Market, Sub-Segmentation of Oral Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets and Capsules
  • Oral Sprays
  • Oral Liquids
  • Oral Disintegrating Tablets
6.5. Global Drug Delivery Devices Market, Sub-Segmentation of Injectable Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Syringes (manual and auto-disable)
  • Vials and Cartridges
  • Pen Injectors
  • Infusion Pumps
6.6. Global Drug Delivery Devices Market, Sub-Segmentation of Topical Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Creams and Ointments
  • Transdermal Patches
  • Gels and Lotions
  • Powders
6.7. Global Drug Delivery Devices Market, Sub-Segmentation of Ocular Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Eye Drops
  • Ocular Inserts
  • Contact Lens Drug Delivery Systems
6.8. Global Drug Delivery Devices Market, Sub-Segmentation of Pulmonary Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered-Dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers
6.9. Global Drug Delivery Devices Market, Sub-Segmentation of Nasal Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Sprays
  • Nasal Powders
  • Nasal Drops
6.10. Global Drug Delivery Devices Market, Sub-Segmentation of Transmucosal Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Buccal Tablets
  • Sublingual Tablets
  • Mucoadhesive Films
6.11. Global Drug Delivery Devices Market, Sub-Segmentation of Implantable Drug Delivery, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Implantable Devices
  • Biodegradable Implants
  • Reservoir-based Implants
7. Drug Delivery Devices Market Regional and Country Analysis
7.1. Global Drug Delivery Devices Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Delivery Devices Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Drug Delivery Devices Market
8.1. Asia-Pacific Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Drug Delivery Devices Market
9.1. China Drug Delivery Devices Market Overview
9.2. China Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Drug Delivery Devices Market
10.1. India Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Drug Delivery Devices Market
11.1. Japan Drug Delivery Devices Market Overview
11.2. Japan Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Drug Delivery Devices Market
12.1. Australia Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Drug Delivery Devices Market
13.1. Indonesia Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Drug Delivery Devices Market
14.1. South Korea Drug Delivery Devices Market Overview
14.2. South Korea Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Drug Delivery Devices Market
15.1. Western Europe Drug Delivery Devices Market Overview
15.2. Western Europe Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Drug Delivery Devices Market
16.1. UK Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Drug Delivery Devices Market
17.1. Germany Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Drug Delivery Devices Market
18.1. France Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Drug Delivery Devices Market
19.1. Italy Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Drug Delivery Devices Market
20.1. Spain Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Drug Delivery Devices Market
21.1. Eastern Europe Drug Delivery Devices Market Overview
21.2. Eastern Europe Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Drug Delivery Devices Market
22.1. Russia Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Drug Delivery Devices Market
23.1. North America Drug Delivery Devices Market Overview
23.2. North America Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Drug Delivery Devices Market
24.1. USA Drug Delivery Devices Market Overview
24.2. USA Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Drug Delivery Devices Market
25.1. Canada Drug Delivery Devices Market Overview
25.2. Canada Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Drug Delivery Devices Market
26.1. South America Drug Delivery Devices Market Overview
26.2. South America Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Drug Delivery Devices Market
27.1. Brazil Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Drug Delivery Devices Market
28.1. Middle East Drug Delivery Devices Market Overview
28.2. Middle East Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Drug Delivery Devices Market
29.1. Africa Drug Delivery Devices Market Overview
29.2. Africa Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Drug Delivery Devices Market Competitive Landscape and Company Profiles
30.1. Drug Delivery Devices Market Competitive Landscape
30.2. Drug Delivery Devices Market Company Profiles
30.2.1. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Baxter International Overview, Products and Services, Strategy and Financial Analysis
30.2.3. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Catalent Overview, Products and Services, Strategy and Financial Analysis
30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis
31. Drug Delivery Devices Market Other Major and Innovative Companies
31.1. West Pharmaceutical Services, Inc.
31.2. Gerresheimer AG
31.3. Smiths Medical
31.4. Boehringer Ingelheim
31.5. SMC Ltd.
31.6. Elcam Medical
31.7. Eli Lilly and Company
31.8. Injex
31.9. Novartis AG
31.10. Novo Nordisk a/S
31.11. Pfizer Inc
31.12. Sanofi Sa
31.13. Schott AG
31.14. Terumo Corporation
31.15. Teva Pharmaceuticals
32. Global Drug Delivery Devices Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Drug Delivery Devices Market34. Recent Developments in the Drug Delivery Devices Market
35. Drug Delivery Devices Market High Potential Countries, Segments and Strategies
35.1 Drug Delivery Devices Market in 2029 - Countries Offering Most New Opportunities
35.2 Drug Delivery Devices Market in 2029 - Segments Offering Most New Opportunities
35.3 Drug Delivery Devices Market in 2029 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Drug Delivery Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug delivery devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Route of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules; Oral Sprays; Oral Liquids; Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable); Vials and Cartridges; Pen Injectors; Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments; Transdermal Patches; Gels and Lotions; Powders
4) By Ocular Drug Delivery: Eye Drops; Ocular Inserts; Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays; Nasal Powders; Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets; Sublingual Tablets; Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices; Biodegradable Implants; Reservoir-based Implants

Key Companies Mentioned: Becton, Dickinson and Company; Baxter International; B. Braun Melsungen AG; Catalent; 3M Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Becton, Dickinson and Company
  • Baxter International
  • B. Braun Melsungen AG
  • Catalent
  • 3M Company
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • Smiths Medical
  • Boehringer Ingelheim
  • SMC Ltd.
  • Elcam Medical
  • Eli Lilly and Company
  • Injex
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc
  • Sanofi Sa
  • Schott AG
  • Terumo Corporation
  • Teva Pharmaceuticals
  • Ypsomed Holding AG
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline
  • AstraZeneca
  • Congenica Ltd.
  • UCB
  • Alkermes
  • Aptalis Pharma, Inc.
  • Johnson & Johnson
  • Nektar Therapeutics
  • SkyePharma PLC
  • Pharmasyntez
  • NEARMEDIC PLUS LLC
  • Copernicus
  • Medtronic
  • Philips
  • Siemens
  • Stryker
  • GE Healthcare
  • Teleflex Medical
  • Gilero
  • Kedalion Therapeutics
  • MediPrint Ophthalmics
  • Nemera
  • Pendant Biosciences
  • Battelle Medical Devices
  • Merck & Co. Inc.
  • Antares Pharma
  • Abbot
  • Allergan
  • Bilim Pharmaceuticals
  • H&T Presspart
  • Hovione Technology
  • Sorrel Medical
  • Syqe Medical
  • Julphar
  • ResMed Inc
  • Covidien plc

Table Information